𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Primary pulmonary diffuse large B-cell lymphoma

✍ Scribed by Tomasz Wróbel; Justyna Dzietczenia; Monika Prochorec–Sobieszek; Grzegorz Mazur; Piotr Piwkowski


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
634 KB
Volume
87
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Prognostic models for diffuse large b-ce
✍ Annarita Conconi; Emanuele Zucca; Enrico Roggero; Francesco Bertoni; Augusto Ber 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 2 views

Prognosis of DLCL patients is variable and associated with well-de®ned risk factors. In the past decade several pretreatment variables have been incorporated into prognostic models to predict the death risk of individual patients. The International Prognostic Index (IPI), developed in an internation

Burkitt lymphoma versus diffuse large B-
✍ Cristiana Bellan; Lazzi Stefano; De Falco Giulia; Emily A Rogena; Leoncini Loren 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 223 KB

## Abstract Burkitt Lymphoma (BL) is listed in the World Health Organization (WHO) classification of lymphoid tumours as an ‘aggressive B‐cell non‐Hodgkin's lymphoma’, characterized by a high degree of proliferation of the malignant cells and deregulation of the c‐MYC gene. The main diagnostic chal

Burkitt lymphoma versus diffuse large B-
✍ Cristiana Bellan; Lazzi Stefano; De Falco Giulia; Emily A. Rogena; Leoncini Lore 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB

## Abstract Burkitt Lymphoma (BL) is listed in the World Health Organization (WHO) classification of lymphoid tumours as an “aggressive B‐cell non‐Hodgkin's lymphoma”, characterized by a high degree of proliferation of the malignant cells and deregulation of the c‐__MYC__ gene. The main diagnostic

Molecular heterogeneity of B-lineage dif
✍ Gisella Volpe; Umberto Vitolo; Antonino Carbone; Cristina Pastore; Marilena Bert 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 948 KB

B-lineage diffuse large cell lymphoma (B-DLCL) arising de novo is chatacterized by a marked degree of clinical heterogeneity. To determine whether or not the clinical heterogeneity of de novo B-DLCL is reflected by heterogeneity in the molecular features of these tumors, we investigated the pattern